Stock-Based Compensation Expenses (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
|---|
| Stock-Based Compensation Expenses [Abstract] |
|
| Schedule of Stock Options Activity |
Stock options activity for the period ended June 30, 2026, is as follows: | | | | Number of
shares options | | | Weighted
average grant date fair value
per share | | | | | | | | | | | | Unvested balance as of December 31, 2025 | | | | 1,691,184 | | | $ | 3.41 | | | Granted | | | | - | | | | - | | | Vested | | | | - | | | | - | | | Forfeited | | | | - | | | | - | | | Unvested balance as of June 30, 2026 | | | | 1,691,184 | | | $ | 3.41 | | | | | | Number of
shares options | | | Weighted
average grant
date fair value
per share | | | | | | | | | | | | | | Exercisable balance as of June 30, 2026 | | | | 5,886,997 | | | $ | 2.26 | |
|
| Schedule of Restricted Stock Awards Activity |
Restricted Stock Awards activity for the six months ended June 30, 2026, is as follows: | | | | Number of
shares RSAs | | | Weighted
average grant
date fair value
per share | | | | | | | | | | | | Unvested balance as of December 31, 2025 | | | | 1,054,638 | | | $ | 7.76 | | | Granted | | | | 957,797 | | | $ | 5.52 | | | Vested | | | | (191,555 | ) | | $ | 5.52 | | | Forfeited | | | | (175,806 | ) | | $ | 7.24 | | | Unvested balance as of June 30, 2026 | | | | 1,645,074 | | | $ | 6.77 | |
|
| Schedule of Common Stock Issued to Consultants as Advisory Shares |
Common stock issued to consultants as advisory shares for the six months ended June 30, 2026 is follows: | Grant dates | | Fair
value on
grant
date | | | Unvested shares
in the beginning | | | Shares granted
during the period | | | Shares vested
during the
period | | | Unvested shares
at the end of
the period | | | 31-Oct-23 | | | 8.99 | | | | 34,541 | | | | - | | | | 6,908 | | | | 27,633 | | | 31-Oct-23 | | | 8.99 | | | | 4,650 | | | | - | | | | 930 | | | | 3,720 | | | 31-Oct-23 | | | 8.99 | | | | 3,700 | | | | - | | | | 740 | | | | 2,960 | | | 31-Oct-23 | | | 8.99 | | | | 14,588 | | | | - | | | | 2,918 | | | | 11,670 | | | | | | | | | | 57,479 | | | | - | | | | 11,496 | | | | 45,983 | |
|
| Schedule of Stock-Based Compensation Expenses |
During the period ended June 30, 2026 and June 30, 2025, the Company recorded share-based compensation expense of $5,322,471 in relation to stock options, RSU and Advisory shares as follows: | | | June 30,
2026 | | | June 30,
2025 | | | Stock options | | $ | 1,429,884 | | | $ | 1,429,884 | | | Restricted stock units (RSU) | | | 3,251,745 | | | | 1,938,783 | | | Advisory shares | | | 640,842 | | | | 640,840 | | | Total stock-based compensation expenses | | $ | 5,322,471 | | | $ | 4,009,507 | |
|
| Schedule of Weighted-Average Estimated Fair Values of Stock Options |
The weighted-average estimated fair values of stock options and the rights to acquire stock as well as the weighted-average assumptions used in calculating the fair values of stock options and the rights to acquire stock that were granted as of June 30, 2026 is as follows: | | | Period ended June 30, 2026 | | | Grant date | | Restricted stock
awards January 09,
2026 | | | Stock Options
February 13,
2024 | | | Stock Options
November 27,
2023 | | | Restricted stock
awards
November 27,
2023 | | | | | | | | | | | | | | | | | Fair value on grant date | | $ | 5.52 | | | $ | 1.39 | | | $ | 3.41 | | | $ | 7.76 | | | Risk free interest rate | | | 4.40 | % | | | 4.40 | % | | | 4.40 | % | | | 4.40 | % | | Expected volatility | | | 18.29 | % | | | 24.96 | % | | | 18.50 | % | | | 18.50 | % | | Exercise prices | | $ | 0.0001 | | | $ | 5.00 | | | $ | 5.00 | | | $ | 0.0001 | | | Share price on the grant date | | $ | 5.52 | | | $ | 5.50 | | | $ | 7.76 | | | $ | 7.76 | | | Expected term of vesting | | | 4 years | | | | 2.5 years | | | | 4 years | | | | 4 years | |
|